Naturex has today announced the subscription of the capital increase launched on 19 June, which has enabled the company to raise a total of € 13.2M through the issue of 266,148 shares at the price of € 49.70.
The new shares are equivalent to the old shares and can be traded on the Eurolist market of Euronext Paris on 26 June 2006 under ISIN code F0000054694.
“We would like to thank all our shareholders, old and new, for having supported us in this operation. We now have the necessary financial resources to continue with our targeted acquisitions policy. We intend to strengthen our position as a leading global player in our business, the extraction and formulation of plant extracts for use in the food and nutraceutical industries” said Jacques Dikansky, the Naturex Chairman.
This operation has been carried out under the aegis of CIC VIZILLE CAPITAL FINANCE, the lead manager and guarantor, CM CIC SECURITIES and NATEXIS BLEICHROEDER, the associated lead managers and bookrunners.
Naturex will release its turnover figures for the first half of 2006 in mid-July.
About our company
Naturex manufactures and sells 100% natural ingredients for the food, flavor, nutraceutical and cosmetics industries.The Group is based in Avignon, France, and is an international company with over 90% of its sales coming from 30 countries outside France, of which 70% generated on the US market.It has facilities in France, Morocco and the United States and a representative office in Singapore.
NATUREX has been listed in Paris since October 1996 - Eurolist C FR0000054694 - Reuters NATU.PA – Bloomberg NTRX
Find all NATUREX press releases in real time on naturexs.com
Your contacts
|
NATUREX Jacques Dikansky – President and CEO Tel : +33 (0)4 90 23 96 89 j.dikansky@naturex.com |
ACTUS Agnès Villeret – Press Relation Tel : +33 (0)1 53 67 36 39 avilleret@actus.fr |